Advertisement

Zydus Cadila gets USFDA nod to market generic tension headache tablets

Follow The Hawk on Google News+ Follow

Advertisement

Drug firm Zydus Cadila on Saturday said it has received final approval from the US health regulator to market generic Butalbital, Acetaminophen and Caffeine combination tablets to treat symptoms of tension headaches.

The company has received final approval from the United States Food and Drug Administration (USFDA) to market Butalbital, Acetaminophen and Caffeine tablets in strengths of 50mg/325mg/40 mg, Zydus Cadila said in a statement.

Advertisement

Also read: Cipla gets USFDA nod for rare genetic condition treatment drug

Also readFSSAI to initiate action against Bisleri over unsafe water sample

The drug will be manufactured at Nesher Pharma's manufacturing facility at St. Louis in the US, it added. This combination medication is used to treat symptom complex of tension (or muscle contraction) headaches, Zydus Cadila said. The group now has 294 approvals and has filed over 390 abbreviated new drug applications (ANDAs) since the commencement of the filing process, it added.

—PTI

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST